The anticipated outcomes of the joint drug procurement initiative by the 26-province alliance have been publicly announced, encompassing two primary categories: contrast agents and gynecological medications. The participating enterprises and their respective prices have been finalized. Additionally, Shandong has embarked on a specific adjustment of online drug prices, mandating that medications priced above the national minimum be rectified within a stipulated timeframe.